To estimate the correlation between high FERMT2 expression and the outcomes of patients with CRC, the PrognoScan web tool was used to analyze the survival outcomes in the CRC patients with higher or lower FERMT2 expression. The gene discussed is FERMT2; the disease is colorectal carcinoma.